Related references
Note: Only part of the references are listed.Rethinking ALS: The FUS about TDP-43
Clotilde Lagier-Tourenne et al.
CELL (2009)
Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior
Fabian Feiguin et al.
FEBS LETTERS (2009)
Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies
Lionel M. Igaz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
TDP-43 Depletion Induces Neuronal Cell Damage through Dysregulation of Rho Family GTPases
Yohei Iguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
TDP-43 localizes in mRNA transcription and processing sites in mammalian neurons
Inigo Casafont et al.
JOURNAL OF STRUCTURAL BIOLOGY (2009)
APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Anatoly Nikolaev et al.
NATURE (2009)
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Iga Wegorzewska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity
Yong-Jie Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease
Emanuele Buratti et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
TDP-43 Overexpression Enhances Exon 7 Inclusion during the Survival of Motor Neuron Pre-mRNA Splicing
Jayarama Krishnan Bose et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cocaine regulates MEF2 to control synaptic and behavioral plasticity
Suprabha Pulipparacharuvil et al.
NEURON (2008)
TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression
Youhna M. Ayala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
TDP-43: a novel neurodegenerative proteinopathy
Mark S. Forman et al.
CURRENT OPINION IN NEUROBIOLOGY (2007)
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases
Hanae Nakashima-Yasuda et al.
ACTA NEUROPATHOLOGICA (2007)
TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein
Michael J. Strong et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2007)
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Catalina Amador-Ortiz et al.
ANNALS OF NEUROLOGY (2007)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)
ARE-mRNA degradation requires the 5 '-3 ' decay pathway
G Stoecklin et al.
EMBO REPORTS (2006)
TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail - An important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing
E Buratti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Human, Drosophila, and C-elegans TDP43:: Nucleic acid binding properties and splicing regulatory function
YM Ayala et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene
PA Mercado et al.
NUCLEIC ACIDS RESEARCH (2005)
Structural diversity and functional implications of the eukaryotic TDP gene family
HY Wang et al.
GENOMICS (2004)
Glial specification in the vertebrate neural tube
DH Rowitch
NATURE REVIEWS NEUROSCIENCE (2004)
Specification of dorsal spinal cord interneurons
AW Helms et al.
CURRENT OPINION IN NEUROBIOLOGY (2003)
Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping
E Buratti et al.
EMBO JOURNAL (2001)
Specificity of Ca2+-dependent protein interactions mediated by the C2A domains of synaptotagmins
S Sugita et al.
BIOCHEMISTRY (2000)
Share Paper
